Skip to content
BidBenchmark

Contractor

UNIVERSITY OF OKLAHOMA

OKLAHOMA CITY, OK
UEI
GY8NMUZQXVS7
Parent UEI
GY8NMUZQXVS7
Resolved by
uei
Confidence
1.000
Obligated to date
$29,189,9641
Awards
20
Agencies served
4

Active from Mar 9, 2026 to Jul 17, 2026.

Recent awards

AwardAgencyPlaceFirst actionCurrent value
36C25923D0003

RADIOPHARMACEUTICALS EO 14398

Department of Veterans AffairsJul 17, 2026
36C25924P0004

PET/CT RADIOPHARMACEUTICALS EO 14398

Department of Veterans AffairsOKJul 14, 2026$279,821
75N91024D00005

PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM

Department of Health and Human ServicesMay 14, 2026
75N91023F00001

TASK ORDER TITLE: COLORECTAL CANCER (CRC) PREVENTION BY TPST-1495 IN PIRC RAT MODEL

Department of Health and Human ServicesOKMar 12, 2026$1,140,397
75N91022F00003

TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201

Department of Health and Human ServicesOKJul 6, 2026$982,258
36C25926P0013

RADIOPHARMACEUTICALS FOR MUS DASH 8 EXTENSION

Department of Veterans AffairsOKJun 30, 2026$358,454
75N91019D00020

EO 14398; PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS

Department of Health and Human ServicesJun 22, 2026
75N91024F00002

TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCER IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS

Department of Health and Human ServicesOKApr 9, 2026$760,552
75N91021F00002

PROJECT TITLE: FURTHER EVALUATION OF AMHR2-ED ANTIGENS FOR EPITHELIAL OVARIAN CARCINOMA

Department of Health and Human ServicesOKJun 17, 2026$1,020,800
36C25922C0002

INTERVENTIONAL RADIOLOGY SERVICES

Department of Veterans AffairsOKJun 16, 2026$1,253,151
75N92019F00074

STRONG HEART STUDY (SHS) - COORDINATING CENTER (CC) - TASK ORDER 001

Department of Health and Human ServicesOKJun 5, 2026$14,413,239
75N91025F00001

EO 14398; TASK ORDER TITLE: FURTHER DEVELOPMENT OF MITOCHONDRIA-TARGETED HONOKIOL FOR PREVENTION OF LUNG CANCER: ADENOCARCINOMA AND SQUAMOUS CELL CARCINOMA

Department of Health and Human ServicesOKJun 5, 2026$1,234,179
75N92019F00074

STRONG HEART STUDY (SHS) - FIELD CENTER (FC) - TASK ORDER 001

Department of Health and Human ServicesOKJun 5, 2026$5,273,991
1333LB24P00000032

ASA RESEARCH FELLOWSHIP- EXERCISE OPTION PERIOD- EXTEND 6 MONTHS

Department of CommerceMDMay 28, 2026$246,680
N0622A26FA106

OK, UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER SPR 1301319610

Department of DefenseOKApr 21, 2026$40,539
N0622A26FA281

UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER SPR 1301336995

Department of DefenseOKApr 21, 2026$70,602
75N91021F00003

PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM, TASK ORDER TITLE: A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER

Department of Health and Human ServicesOKApr 10, 2026$1,107,542
N0622A26FA058

TUITION AND FEES OK, UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER

Department of DefenseOKApr 9, 2026$19,987
75N91020F00005

EVALUATION OF TWO DIFFERENT CLASSES OF COMPOUNDS (STAT3 INHIBITORS AND SERMS) FOR THE PREVENTION OF URINARY BLADDER CANCER.

Department of Health and Human ServicesOKMar 18, 2026$909,994
N0622A25FA370

TUITION AND FEES

Department of DefenseOKMar 9, 2026$77,778

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.

  1. 1Awards are attributed by Unique Entity Identifier GY8NMUZQXVS7, the government's own recipient identifier, not by name matching.
  2. 2Award records from USAspending.gov, last refreshed Aug 10, 2026.
UNIVERSITY OF OKLAHOMA federal contracts · BidBenchmark